Cytometry of antitumor drug-intracellular target interactions.
Smith
P J
PJ
Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
Wiltshire
M
M
D000970:Antineoplastic Agents / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D001562:Benzimidazoles / Q000378:metabolism; D002453:Cell Cycle; D004247:DNA / Q000187:drug effects / Q000378:metabolism*; D053938:DNA Fragmentation; D004264:DNA Topoisomerases, Type I / Q000378:metabolism*; D016503:Drug Delivery Systems; D005047:Etoposide / Q000494:pharmacology; D005434:Flow Cytometry / Q000379:methods*; D005456:Fluorescent Dyes / Q000378:metabolism; D006801:Humans; D008024:Ligands; D018613:Microscopy, Confocal; D059004:Topoisomerase I Inhibitors; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D001562:Benzimidazoles; D005456:Fluorescent Dyes; D008024:Ligands; D059004:Topoisomerase I Inhibitors; D005047:Etoposide; D004247:DNA; D004264:DNA Topoisomerases, Type I; C017807:bisbenzimide ethoxide trihydrochloride